Cindy Walden Authors, "Brand Owner's Friend: the Lanham Act at 75"

Authors

Name

Cynthia Johnson Walden

Person title

Principal

Fish Principal Cindy Walden recently wrote about the 75th anniversary of the Lanham Act. This historic piece of legislation helps businesses protect their trademark rights.

Read the full article (PDF).

The opinions expressed are those of the authors on the date noted above and do not necessarily reflect the views of Fish & Richardson P.C., any other of its lawyers, its clients, or any of its or their respective affiliates. This post is for general information purposes only and is not intended to be and should not be taken as legal advice. No attorney-client relationship is formed.

Brand Owner's Friend: the Lanham Act at 75

World IP Review

Authors

USPTO Warns Trademark Applicants to Beware of Spoofed Calls

USPTO Updates Deadline to Respond to Trademark Office Actions

Selling the Intangible in Fashion: What Does It Mean for Trademark Protection?

Q&A with Cynthia Walden for Westlaw

Trademark, Copyright Legislation Passed as Part of COVID-19 Relief Bill

Essential Steps Every Brand Owner Should Take to Combat Counterfeiting

2018 Trademark and Copyright Year in Review

First Amendment 2 — Lanham Act 0: Federal Circuit Holds Lanham Act Prohibition on Immoral and Scandalous Marks Is Unconstitutional Restriction on Free...

Matal v. Tam : The Supreme Court Sacks the Ban on Disparaging Trademarks

Is This "The End" for Unicorn Beverages? Starbucks Sued Over Unicorn Frappuccino

Lack of Bona Fide Intent to Use Sends Alcohol Trademark Application Down the Drain

Green Glove Trademark Application Gets Red Light From Federal Circuit

Federal Circuit Reverses Injunction That Barred Clinical Trials in Jazz v. Avadel

John Squires Faces the Senate Judiciary Committee

HHS Sets Most-Favored-Nation Price Targets for Pharmaceuticals

No Space at the Trademark Office for US SPACE FORCE

How Trump’s Latest Drug Price EO Could Impact Pharma

Patent Diligence for VCs and PEs

More Is More: Ensure Your Mark Is Protectable Before You Enforce

Can Clinical Trials Negate Patentability for Pharma Inventions?